Angiotensin blocking drugs and the heart beyond 2000

Journal of the American Society of Nephrology

Volumn 10, Issue 1 SUPPL. 11, 1999, Pages

  Morgan, Trefor Owen ^a   Delbridge, Leanne M D ^a  

^a UNIVERSITY OF MELBOURNE   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

ANGIOTENSIN; ANGIOTENSIN 1 RECEPTOR; ANGIOTENSIN 1 RECEPTOR ANTAGONIST; ANGIOTENSIN 2 RECEPTOR; ANGIOTENSIN ANTAGONIST; BRADYKININ; CAPTOPRIL; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; LOSARTAN; RAMIPRIL; RENIN;

BLOOD PRESSURE REGULATION; DRUG RESEARCH; HEART HYPERTROPHY; HORMONAL REGULATION; HUMAN; HYPERTENSION; NONHUMAN; PRIORITY JOURNAL; RECEPTOR BLOCKING; RENIN ANGIOTENSIN ALDOSTERONE SYSTEM; REVIEW;

EID: 0032951380     PISSN: 10466673     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (39)

1. Fagard RH, Staessen JA, Thijs L: Prediction of cardiac structure and function by repeated clinic and ambulatory blood pressure. Hypertension 29: 22-29, 1997
2. Ruzicka M. Yuan B, Harmsen E, Leenen FH: The renin-angio-tensin system and volume overload-induced carciad hypertrophy in rats: Effects of angiotensin converting enzyme inhibitor versus angiotensin II receptor blocker. Circulation 87: 921-930, 1993
3. Iwai N, Shimoike H, Kinoshita M: Cardiac renin-angiotensin system in the hypertrophied heart. Circulation 92: 2690-2696, 1996
4. Gerdes AM, Capasso JM: Structural remodelling and mechanism dysfunction of cardiac myocytes in heart failure. J Mol Cell Cardiol 27: 849-856, 1995
5. Arai M, Matsui H, Periasamy M: Sarcoplasmic reticulum gene expression in cardiac hypertrophy and heart failure. Circ Res 74: 555-564, 1994
6. Morgan T, Brunner H, Aubert J-F, Connell P: The relationship of blood pressure to cardiac hypertrophy: Experimental studies in rats. Clin Exp Hypertens 19: 827-841, 1997
7. Morgan TO, Aubert J-F, Wang Q: Sodium, angiotensin II, blood pressure, and cardiac hypertrophy. Kidney Int 54[Suppl 67]: S213-S215, 1998
8. Battle T, Schnell C, Bunkenburg B, Heudes D, Wood JM, Ménard J: Continuous versus intermittent angiotensin converting enzyme inhibition in renal hypertensive rats. Hypertension 22: 188-196, 1993
9. Morgan TO, Aubert J-F, Wang Q, Brunner HR: Cardiac hypertrophy depends more on sleep than awake blood pressure [Abstract]. J Hypertens 16[Suppl 2]: S127, 1998
10. Golstein J, Van Cauter E, Désir D, Noël P, Spire JP, Refetoff S: Effect of "jet lag" on hormonal patterns. IV. Time shifts increase growth hormone release. J Clin Endocrinol Metab 56: 433-440, 1983
11. Brandenberger G, Follenius M, Goichot B, Saini J, Spiegel K, Ehrhart J: Twenty-four hour profiles of plasma renin activity in relation to the sleep-wake cycle. J Hypertens 12: 277-283, 1994
12. Danser AHJ, Schalekamp MADH: Is there an internal cardiac renin angiotensin system? Heart 76[Suppl 3]: 28-32, 1996
13. Dostal DE, Rothblum KN, Conrad KM, Cooper GR, Baker KM: Detection of angiotensin I and II in cultured rat cardiac myocytes and fibroblasts. Am J Physiol 263: C851-C863, 1992
14. Danser AH, de Lannoy LM, Sarena PR, Schalekamp MADH: Localization and production of angiotensin II in the heart [Abstract]. J Am Coll Cardiol 31[5 Suppl C 71C]: 619, 1998
15. Müller DN, Fischli W, Clozel JP: Local angiotensin II generation in the rat heart: Role of renin uptake. Circ Res 82: 13-20, 1998
16. Sadoshima J, Xu Y, Slayter HS, Izumo S: Autocrine release of angiotensin II mediates stretch induced hypertrophy of cardiac myocytes. Cell 75: 977-984, 1993
17. Yamazaki T, Komuro I, Kudoh S: Angiotensin II partly mediates mechanical stress induced cardiac hypertrophy. Circ Res 77: 258-265, 1995
18. Delbridge LM, Morgan TO, Harris PJ: Effects of endothelin-1 on the contractility of cardiomyocytes from the spontaneously hypertensive rat. Clin Exp Pharmacol Physiol 22: 755-762, 1995
19. Haller H, Lindschau C, Erdmann B, Quass P, Luft FC: Effect of intracellular angiotensin II in vascular smooth muscle cells. Circ Res 79: 765-772, 1996
20. Haller H, Lindschau C, Quass P, Luft FC: Intracellular actions of angiotensin II in vascular smooth muscle cells. J Am Soc Nephrol 10: S75-S83, 1999
21. Yamazaki T, Tobe K, Hoh E, Maemura K, Kaida T, Komuro I: Mechanical loading activates mitogen activated protein kinase and S6 peptide kinase in cultured rat cardiac myocytes. J Biol Chem 268: 12069-12076, 1993
22. 1 receptor subtype. Circ Res 13: 413-423, 1993
23. Dahlof B, Pennert K, Hansson L: Reversal of left ventricular hypertrophy in hypertensive patients: A meta analysis of 109 treatment studies. Am J Hypertens 5: 95-110, 1992
24. Linz W, Schaper J, Wiemer G, Albus U, Schölkens BA: Ramipril prevents left ventricular hypertrophy with myocardial fibrosis without blood pressure reduction: A one year study in rats. Br J Pharmacol 107: 970-975, 1992
25. Rhaleb NE, Yang XP, Scicli AG, Carretero OA: Role of kinins and nitric oxide in the antihypertrophic effect of ramipril. Hypertension 23: 865-868, 1994
26. Morgan TO, Aubert J-F, Wang Q, Brunner HR: Importance of BP, NaCl, angiotensin II (Ang II) or bradykinin in resolution of cardiac hypertrophy [Abstract]. J Hypertens 16[Suppl 2]: S337, 1998
27. Menard J, Campbell DJ, Azizi M, Gonzales MF: Synergistic effects of ACE inhibition and Ang II antagonism on blood pressure, cardiac weight, and renin in spontaneously hypertensive rats. Circulation 96: 3072-3078, 1997
28. Esther CR, Marino EM, Howard TE, Machaud A, Corvol P, Capecchi MR: The critical role of tissue angiotensin-converting enzyme as revealed by gene targeting in mice. J Clin Invest 99: 2375-2385, 1997
29. Adamian KG, Chilingarian AL, Astivatsatrian AV, Gharibgeanian AZ, Astivatsatrian TR, Vardanian SI: Concomitant angiotension II receptor blockade and angiotensin converting enzyme inhibitor in alteration of left ventricular remodelling [Abstract]. J Am Coll Cardiol 31[5 Suppl C 7C]: 90, 1998
30. Morgan T, Anderson A, Jones E: The effect of 24 h blood pressure control of an angiotensin converting enzyme inhibitor (perindopril) administered in the morning or at night. J Hypertens 15: 205-211, 1997
31. Palatini P, Mos L, Motolese M, Morrnino P, DelTorre M, Varotto L: Effect of evening versus morning benazepril on 24-hour blood pressure: A comparative study with continuous intraarterial monitoring. Int J Clin Pharmacol Ther Toxicol 31: 295-300, 1993
32. Smith DHG, Neutel JM, Black HR, Schoenberger JA, Weber MA: Once-daily therapy with trandolapril in the treatment of hypertension. J Hum Hypertens 10: 129-134, 1996
33. Kim S, Kawamura M, Wanibuchi H, Ohta K, Hamaguchi A, Omura T: Angiotensin II type I receptor blockade inhibits the expression of immediate-early genes and fibronectin in rat injured artery. Circulation 92: 88-95, 1995
34. 1-receptor antagonist on gene expression and the cellular phenotype. J Hypertens 15[Suppl 6]: S3-S7, 1997
35. Kim S, Ohta K, Hamaguchi A, Omura T, Yukimura T, Miura K: Contribution of renal angiotensin II type I receptor to gene expressions in hypertension-induced renal injury. Kidney Int 46: 1346-1358, 1994
36. Webber MA: Comparison of type 1 angiotensin II receptor blockers and angiotensin converting enzyme inhibitors in the treatment of hypertension. J Hypertens 15[Suppl 6]: S31-S36, 1997
37. Pitt B, Segal R, Martinez FA: Randomised trial of losartan versus captopril in patients over 65 with heart failure (Evaluation of Losartan in the Elderly Study, ELITE). Lancet 349: 747-752, 1997
38. Sever P, Holzgreve H: Long term efficacy and tolerability of candesartan cilexatil in patients with mild to moderate hypertension. J Hum Hypertens 11[Suppl 2]: S69-S73, 1997
39. McInnes GT, O'Kane KPT, Jonker T, Roth T: The efficacy and tolerability of candesartan cilexatil in an elderly hypertensive population. J Hum Hypertens 11[Suppl 2]: S75-S80, 1997